Conference
The effect of duration of therapy on the benefit of fondaparinux over enoxaparin in acute coronary syndromes: insights from the OASIS 5 trial
Authors
Jolly S; Mehta SR; Wallentin L; Afzal R; Budaj A; Fox KAA; Col J; Rupprecht HJ; Granger CB; Yusuf S
Volume
28
Pagination
pp. 187-187
Publisher
OXFORD UNIV PRESS
Publication Date
September 1, 2007
Conference proceedings
EUROPEAN HEART JOURNAL
ISSN
0195-668X